Olesoxime: Pivotal trial started

Trophos began a 24-month, double-blind, placebo-controlled, European pivotal trial to evaluate 10 mg/kg/day olesoxime in about 160 non-ambulant patients with SMA. Olesoxime has Orphan Drug designation...